Trial
NCT04876716
Azole-echinocandin Combination Therapy for Invasive Aspergillosis
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Erasmus Medical Center
Collaborators
ZonMw: The Netherlands Organisation for Health Research and Development; Stichting Hemato-Oncologie voor Volwassenen Nederland
Condition
Invasive Aspergillosis
Intervention
Azole
Why stopped
futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-05-07